Jupiter Neurosciences, Inc. (JUNS)
2.20
+0.07
(+3.29%)
USD |
NASDAQ |
Nov 06, 16:00
2.01
-0.19
(-8.64%)
After-Hours: 20:00
Jupiter Neurosciences EPS Diluted (Quarterly) : -4.079 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.079 |
| March 31, 2026 | -4.387 |
| December 31, 2025 | -5.606 |
| September 30, 2025 | -5.042 |
| June 30, 2025 | -5.092 |
| March 31, 2025 | -3.464 |
| December 31, 2024 | -3.461 |
| September 30, 2024 | -1.339 |
| June 30, 2024 | 0.7095 |
| March 31, 2024 | -1.436 |
| December 31, 2023 | -0.9735 |
| Date | Value |
|---|---|
| September 30, 2023 | -4.019 |
| June 30, 2023 | -1.900 |
| March 31, 2023 | -3.986 |
| December 31, 2022 | -3.987 |
| September 30, 2022 | -12.13 |
| June 30, 2022 | -6.663 |
| March 31, 2022 | -6.181 |
| December 31, 2021 | -14.83 |
| September 30, 2021 | -9.256 |
| March 31, 2021 | -1.796 |
| September 30, 2020 | -3.796 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 0.0858 |
| ANI Pharmaceuticals, Inc. | 1.510 |
| Corcept Therapeutics, Inc. | 1.010 |
| Veru, Inc. | -0.3032 |
| Eli Lilly & Co. | 7.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.274M |
| Revenue (Quarterly) | 0.0242M |
| Total Expenses (Quarterly) | 2.299M |
| Enterprise Value | 1.716M |
| Gross Profit Margin (Quarterly) | 87.19% |
| Profit Margin (Quarterly) | -9.40K% |
| Earnings Yield | -868.8% |
| Normalized Earnings Yield | -919.74 |